Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2010 1
2011 2
2012 1
2016 1
2017 3
2018 5
2019 6
2020 11
2021 10
2022 12
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Impact of Pretransplantation Physical Function on Transplantation after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Gomyo A, Kimura SI, Suzuki J, Ishikawa T, Meno T, Matsuoka A, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Okada Y, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Sato M, Tanihara A, Sekine K, Nakasone H, Kako S, Kanda Y. Gomyo A, et al. Among authors: yoshimura k. Transplant Cell Ther. 2023 Nov;29(11):721.e1-721.e8. doi: 10.1016/j.jtct.2023.08.023. Epub 2023 Aug 27. Transplant Cell Ther. 2023. PMID: 37643718
Secondary Budd-Chiari syndrome caused by adult T-cell leukemia/lymphoma.
Tominaga R, Yoshimura K, Kawamura M, Kako S, Kanda Y, Morikawa H, Ando S, Okabe N, Hiruta M, Tanaka A, Oshiro H. Tominaga R, et al. Among authors: yoshimura k. Pathol Int. 2023 Oct;73(10):520-522. doi: 10.1111/pin.13358. Epub 2023 Aug 2. Pathol Int. 2023. PMID: 37530496 No abstract available.
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation.
Matsumi S, Kimura SI, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Okada Y, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Tanihara A, Sato M, Nakasone H, Kako S, Kanda Y. Matsumi S, et al. Among authors: yoshimura k. Int J Hematol. 2023 Oct;118(4):450-461. doi: 10.1007/s12185-023-03645-4. Epub 2023 Jul 22. Int J Hematol. 2023. PMID: 37480446
Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantation.
Okada Y, Nakasone H, Yoshimura K, Tamaki M, Kusuda M, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Gomyo A, Tanihara A, Kimura SI, Kako S, Kanda Y. Okada Y, et al. Among authors: yoshimura k. Int J Hematol. 2023 Sep;118(3):340-346. doi: 10.1007/s12185-023-03642-7. Epub 2023 Jul 22. Int J Hematol. 2023. PMID: 37480445
Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients.
Kusuda M, Nakasone H, Yoshimura K, Okada Y, Tamaki M, Matsuoka A, Ishikawa T, Meno T, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Gomyo A, Tanihara A, Kimura SI, Kako S, Kanda Y. Kusuda M, et al. Among authors: yoshimura k. Br J Haematol. 2023 Aug;202(3):578-588. doi: 10.1111/bjh.18918. Epub 2023 Jun 15. Br J Haematol. 2023. PMID: 37317804
[Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease after allogeneic hematopoietic cell transplantation successfully treated with triple immunosuppressive therapy].
Nakamura Y, Kawamura S, Matsumi S, Matsumoto K, Tanaka S, Ishikawa T, Matsuoka A, Meno T, Kawamura M, Takeshita J, Yoshino N, Yoshimura K, Misaki Y, Gomyo A, Okada Y, Tamaki M, Kusuda M, Akahoshi Y, Kameda K, Wada H, Kimura SI, Nakasone H, Kako S, Date H, Kanda Y. Nakamura Y, et al. Among authors: yoshimura k. Rinsho Ketsueki. 2023;64(4):250-254. doi: 10.11406/rinketsu.64.250. Rinsho Ketsueki. 2023. PMID: 37121767 Japanese.
Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.
Yoshino N, Kimura SI, Matsuoka A, Meno T, Ishikawa T, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Misaki Y, Yoshimura K, Gomyo A, Okada Y, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Tanihara A, Wada H, Nakasone H, Kako S, Kanda Y. Yoshino N, et al. Among authors: yoshimura k. J Infect Chemother. 2023 Apr;29(4):384-390. doi: 10.1016/j.jiac.2023.01.004. Epub 2023 Jan 18. J Infect Chemother. 2023. PMID: 36669687
Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Kimura SI, Shimizu H, Miyazaki T, Sakurai M, Tanoue S, Kayamori K, Ohwada C, Yoshimura K, Nakasone H, Ohashi T, Shono K, Tachibana T, Hatano K, Okada K, Kimura Y, Seo S, Doki N, Tanaka M, Hatta Y, Takahashi S, Kanda Y; Kanto Study Group for Cell Therapy. Kimura SI, et al. Among authors: yoshimura k. Bone Marrow Transplant. 2023 Apr;58(4):452-455. doi: 10.1038/s41409-022-01901-5. Epub 2022 Dec 26. Bone Marrow Transplant. 2023. PMID: 36572728 No abstract available.
Chronic active Epstein-Bar virus infection complicated by pulmonary artery hypertension.
Misaki Y, Minakata D, Ibe T, Gomyo A, Yoshimura K, Kimura SI, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Matsumi S, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Tanihara A, Hatano K, Nakasone H, Imadome KI, Wada H, Kako S, Oshiro H, Tanaka A, Kanda Y. Misaki Y, et al. Among authors: yoshimura k. J Infect Chemother. 2023 Feb;29(2):212-218. doi: 10.1016/j.jiac.2022.10.013. Epub 2022 Oct 28. J Infect Chemother. 2023. PMID: 36374666
58 results